Upcoming events – Crowded markets ahead for TG and Redhill
TG and Redhill are expecting phase III data soon, but both have a fight ahead to make their mark even if their projects succeed.
Kickstarting ideas
Independent, data-driven daily news and analysis on pharma, biotech and medtech.